Page last updated: 2024-08-23

buserelin and Breast Neoplasms

buserelin has been researched along with Breast Neoplasms in 97 studies

Research

Studies (97)

Timeframe	Studies, this research(%)	All Research%
pre-1990	47 (48.45)	18.7374
1990's	40 (41.24)	18.2507
2000's	7 (7.22)	29.6817
2010's	3 (3.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benabu, JC; Gabriele, V; Mathelin, C; Ohl, J; Youssef, CA	1
Anikus'ko, NF; Liubota, II; Liubota, RV; Shchepotin, IB; Zotov, AS	1
Aguilar-Rojas, A; Arechavaleta-Velásco, F; Conn, PM; Huerta-Reyes, M; Maya-Núñez, G; Ulloa-Aguirre, A; Valdés, J	1
Finch, AR; Green, L; Hislop, JN; Kelly, E; McArdle, CA	1
Noguchi, S; Taguchi, T	1
de Jong, FH; Klijn, JG	1
Waxman, J	1
Alexieva-Figusch, J; Blankenstein, MA; Blonk-van der Wijst, J; de Jong, FH; Docter, R; Klijn, JG; Lamberts, SW	1
Klijn, JG	1
Carpano, S; Di Lauro, L; Lopez, M; Natali, M; Pignatti, F; Vici, P	1
Bramley, T; Menzies, G; Miller, B; Mullen, P	1
Bastert, G; Baumann, KH; Kaufmann, M; Kiesel, L; Runnebaum, B	1
Bosin, E; Hershkovitz, E; LeRoith, D; Levy, J; Marbach, M; Roberts, CT; Schally, AV; Sharoni, Y	1
Davidson, NE	1
Becquart, D; Beex, LV; Burghouts, J; Duchateau, L; Jassem, J; Klijn, JG; Mauriac, L; Mignolet, F; Piccart, M; Seynaeve, C; van Zijl, JA; Veyret, C; Wildiers, J	1
Powles, TJ	1
Blamey, RW; Boccardo, F; Duchateau, L; Klijn, JG; Sylvester, R; Tominaga, T	1
Illiger, HJ; Willeke, K	1
Falkson, CI; Falkson, G; Falkson, HC	2
Kitroser, H; Levy, J; Schally, AV; Segal-Abramson, T; Sharoni, Y	1
Brower, ST; Hollander, VP; Redding, TW; Schally, AV	1
Bajor, T; Balogh, A; Bökönyi, G; Horváth, A; Horváth, J; Kéri, G; Mezö, I; Teplán, I; Vadász, Z; Vántus, T	1
Bianco, AR; Blamey, RW; Jonat, W; Kaufmann, M; Namer, M	1
Coombes, RC; Dowsett, M; Stein, RC	1
Aakvaag, A; Johannessen, DC; Lien, EA; Lønning, PE	1
Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF	1
Artioli, R; Brambilla, C; Escobedo, A; Lechuga, MJ; Motta, M	1
Höffken, K	1
Chrisp, P; Goa, KL	1
Coombes, RC; Ford, HT; Gazet, JC	1
Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC	1
Carpano, S; Di Lauro, L; Lopez, M; Veltri, E; Vici, P	1
Artioli, R; Bonadonna, G; Brambilla, C; Escobedo, A; Lechuga, MJ; Motta, M	1
Bastert, G; Jonat, W; Kaufmann, M; Maass, H; Schachner-Wünschmann, E	1
Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF	1
Blamey, RW; Bouzubar, N; Dixon, AR; Ellis, IO; McClelland, R; Nicholson, RI; Robertson, JF; Walker, KJ	1
Miller, WR; Mullen, P; Scott, WN	2
Bianco, AR; Calabresi, F; De Placido, S; Fiorentino, M; Fosser, V; Lenti, R; Lopez, M; Perrone, F; Rosso, R; Sismondi, PG	1
Balogh, A; Csuka, O; Kéri, G; Szöke, B; Teplán, I	1
Anderson, H; Dodwell, DJ; Howell, A	1
Falkay, G; Kahán, Z	1
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR	2
Bouzubar, N; Davies, P; Gee, JM; Nicholson, RI; Rushmere, NK; Walker, KJ; Wills, RJ	1
Gez, E; Kovner, F	1
Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC	1
Distler, W; von Matthiessen, H	1
Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H	1
Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF; Walker, KJ	1
Blamey, RW; Dixon, A; McClelland, RA; Nicholson, RI; Robertson, JF; Walker, KJ	1
Cortese, P; Defabiani, E; Giai, M; Sismondi, P	1
Falkson, G; Falkson, HC	1
Blamey, RW; Griffiths, K; Nicholson, RI; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF	1
Hartmann, A; Mann, K	1
Albrecht, M; Eiermann, W; Hilfrich, J; Jänicke, F; Jonat, W; Kaufmann, M; Kleeberg, U; Kreienberg, R; Schmid, H; Weitzel, HK	1
Cantwell, BM; Carmichael, J; Dowsett, M; Harris, AL	2
Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA	1
Kaufmann, M; Schachner-Wünschmann, E; Schmid, H	1
Nicholson, RI; Walker, KJ	2
Blamey, RW; Nicholson, RI; Robertson, JF; Walker, KJ	2
Blamey, RW; Nicholson, RI; Read, GF; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF	1
Kaufmann, M	1
Cantwell, BM; Dowsett, M; Harris, AL	1
Tyrrell, C	1
Abeloff, M; Dalton, WS; Osborne, CK; Robert, NJ	1
Jonat, W	1
Cheson, BD	1
Astone, A; Barone, C; Cassano, A; Garufi, C; Noviello, MR; Pietrantonio, F	1
Barni, S; Cattaneo, G; Crispino, S; Lissoni, P; Tancini, G	1
Haeseler, F; Kaufmann, M; Kiesel, L; Klinga, K; Runnebaum, B; Schmidt, W; von Holst, T	1
Blamey, RW; Dyas, J; Nicholson, RI; Plowman, PN; Turkes, A; Walker, KJ; Williams, M	1
Blamey, RW; Nicholson, RI; Turkes, A; Walker, KJ; Williams, MR	2
Nicholson, RI; Plowman, PN; Walker, KJ	1
Blamey, RW; Robertson, JF	1
Cantwell, B; Dowsett, M; Harris, AL; Jeffcoate, SL; Lal, A	1
Blamey, RW; Ellis, IO; Elston, CW; Nicholson, RI; Robertson, JF; Williamson, K	1
Kaufmann, M; Kiesel, L; Klinga, K; Schmid, H	1
Eidne, KA; Flanagan, CA; Harris, NS; Millar, RP	1
Harvey, H; Lipton, A; Manni, A; Max, D; Santen, R	1
Burger, HG; Healy, DL; McLachlan, RI	1
Blankenstein, MA; Foekens, JA; Fukkink, JF; Henkelman, MS; Klijn, JG	1
Falkson, G; Vorobiof, DA	1
Baird, DT; Fraser, HM	1
Doberauer, C; Niederle, N; Schmidt, CG	1
Ferrari, V; Marini, G; Marpicati, E; Montini, E; Moretti, R; Simoncini, E; Zaniboni, A	1
Coombes, RC; Harland, SJ; Lister, TA; Malpas, JS; Powles, T; Waxman, JH; Wrigley, PF	1
Becher, R; Höffken, K; Miller, AA; Miller, B; Schmidt, CG	1
Nillius, SJ	1
Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW	1
Blankenstein, MA; Henkelman, MS; Klijn, JG	1

Reviews

15 review(s) available for buserelin and Breast Neoplasms

Article	Year
[Does fertility treatment increase the risk of breast cancer? Current knowledge and meta-analysis]. Gynecologie, obstetrique, fertilite & senologie, 2017, Volume: 45, Issue:5 Topics: Breast Neoplasms; Buserelin; Clomiphene; Female; Fertility Agents; Humans; Infertility, Female; Ovulation Induction; Reproductive Techniques, Assisted; Risk Factors	2017
[Clinical applications of GnRHa in breast cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 4 Topics: Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Ovariectomy; Randomized Controlled Trials as Topic; Tamoxifen	2006
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-15, Volume: 19, Issue:2 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Premenopause; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen	2001
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3 Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause	1992
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions. Drugs, 1991, Volume: 41, Issue:2 Topics: Animals; Breast Neoplasms; Buserelin; Drug Evaluation; Endometriosis; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Goserelin; Humans; Leiomyoma; Male; Menstruation Disturbances; Polycystic Ovary Syndrome; Prostatic Neoplasms; Uterine Neoplasms	1991
New endocrine approaches to breast cancer. Bailliere's clinical endocrinology and metabolism, 1990, Volume: 4, Issue:1 Topics: Androgen Antagonists; Animals; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteolytic Agents; Progestins; Rats; Somatostatin; Triptorelin Pamoate	1990
[Therapeutic use of a gonadotropin releasing hormone analogue in breast cancer]. Orvosi hetilap, 1990, May-13, Volume: 131, Issue:19 Topics: Breast Neoplasms; Buserelin; Estrogens; Female; Gonadotropins; Humans; Middle Aged; Pituitary Hormone-Releasing Hormones; Progesterone	1990
[Luteinizing hormone-releasing hormone agonists for treatment of breast cancer]. Harefuah, 1990, Jun-01, Volume: 118, Issue:11 Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Gonadotropin-Releasing Hormone; Goserelin; Humans	1990
New trends in the endocrine treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1990
[Zoladex in the treatment of mammary carcinoma]. Drugs under experimental and clinical research, 1990, Volume: 16 Suppl Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Buserelin; Goserelin; Humans; Mammary Neoplasms, Experimental	1990
Gn-RH agonists in breast and gynaecologic cancer treatment. Journal of steroid biochemistry, 1989, Volume: 33, Issue:4B Topics: Animals; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Genital Neoplasms, Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Rats; Rats, Inbred Strains	1989
Clinical aspects of LHRH analogues in gynaecology: a review. British journal of obstetrics and gynaecology, 1986, Volume: 93, Issue:5 Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms	1986
Clinical applications of LHRH analogues. Bailliere's clinical endocrinology and metabolism, 1987, Volume: 1, Issue:1 Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Leiomyoma; Male; Ovulation; Ovulation Induction; Premenstrual Syndrome; Prostatic Neoplasms; Puberty, Precocious; Uterine Neoplasms; Uterus	1987
[Hormone therapy of metastatic breast carcinoma]. Deutsche medizinische Wochenschrift (1946), 1985, Nov-22, Volume: 110, Issue:47 Topics: Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Menopause; Neoplasm Metastasis	1985
Gonadotrophin-releasing hormone agonists for new approaches to contraception in man. Wiener klinische Wochenschrift, 1985, Dec-06, Volume: 97, Issue:23 Topics: Abortion, Induced; Administration, Intranasal; Breast Neoplasms; Buserelin; Contraception; Corpus Luteum; Erectile Dysfunction; Female; Hormones; Humans; Male; Norethindrone; Oligospermia; Ovulation; Pituitary Hormone-Releasing Hormones; Risk; Testosterone	1985

Trials

19 trial(s) available for buserelin and Breast Neoplasms

Article	Year
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer. Breast cancer research and treatment, 1984, Volume: 4, Issue:3 Topics: Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. Journal of the National Cancer Institute, 2000, Jun-07, Volume: 92, Issue:11 Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Disease-Free Survival; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Humans; Menstrual Cycle; Middle Aged; Premenopause; Prognosis; Prospective Studies; Risk Factors; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome	2000
[Combination therapy with buserelin and tamoxifen in metastatic breast cancer in premenopause: a randomized study]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2001, Volume: 177, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Disease Progression; Disease-Free Survival; Female; Humans; Premenopause; Tamoxifen; Time Factors	2001
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Delayed-Action Preparations; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Ovary	1992
Goserelin depot in the treatment of premenopausal advanced breast cancer. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:4-5 Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Menstruation; Middle Aged	1992
LH-RH agonists in the treatment of premenopausal patients with advanced breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1992, Volume: 124 Topics: Adult; Breast Neoplasms; Buserelin; Female; Hormones; Humans; Middle Aged	1992
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study). British journal of cancer, 1991, Volume: 63, Issue:2 Topics: Adult; Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Pilot Projects; Receptors, Estrogen	1991
Primary systemic therapy for operable breast cancer. British journal of cancer, 1991, Volume: 63, Issue:4 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen	1991
The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group. Onkologie, 1991, Volume: 14, Issue:1 Topics: Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Middle Aged; Neoplasm Metastasis	1991
Effect of chemotherapy with or without buserelin on serum hormone levels in premenopausal women with breast cancer. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Doxorubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Methotrexate; Middle Aged; Ovary; Time Factors	1991
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study). European journal of gynaecological oncology, 1991, Volume: 12, Issue:6 Topics: Adult; Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Life Tables; Luteinizing Hormone; Menopause; Middle Aged	1991
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer. British journal of cancer, 1990, Volume: 62, Issue:4 Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy	1990
New trends in the endocrine treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1990
Zoladex plus tamoxifen versus Zoladex alone in pre- and peri-menopausal metastatic breast cancer. The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cell Transformation, Neoplastic; Female; Freezing; Goserelin; Humans; Immunoenzyme Techniques; Middle Aged; Receptors, Estrogen; Remission Induction; Solubility; Tamoxifen	1990
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8 Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Menopause; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Remission Induction	1989
Zoladex in the treatment of premenopausal metastatic breast cancer patients. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Abdominal Neoplasms; Bone Neoplasms; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Multicenter Studies as Topic	1989
A multi-centre randomised study to compare the effects of ovarian ablation with Zoladex depot in pre- and perimenopausal patients with advanced breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Multicenter Studies as Topic; Ovariectomy; Randomized Controlled Trials as Topic	1989
Clinical aspects of LHRH analogues in gynaecology: a review. British journal of obstetrics and gynaecology, 1986, Volume: 93, Issue:5 Topics: Adolescent; Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Contraceptive Agents, Female; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hypogonadism; Infertility, Female; Leiomyoma; Menstruation Disturbances; Pituitary Gland; Polycystic Ovary Syndrome; Uterine Neoplasms	1986
LHRH-agonist treatment in clinical and experimental human breast cancer. Journal of steroid biochemistry, 1985, Volume: 23, Issue:5B Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen	1985

Other Studies

65 other study(ies) available for buserelin and Breast Neoplasms

Article	Year
[Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause]. Voprosy onkologii, 2013, Volume: 59, Issue:3 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Leuprolide; Middle Aged; Ovary; Perimenopause; Premenopause; Survival Analysis; Treatment Outcome; Triptorelin Pamoate	2013
Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231. BMC cancer, 2012, Nov-23, Volume: 12 Topics: Actins; Breast Neoplasms; Buserelin; Cell Line, Tumor; Cell Movement; Enzyme Activation; Female; Flow Cytometry; Fluorometry; Focal Adhesions; Gonadotropin-Releasing Hormone; Humans; Immunoblotting; MCF-7 Cells; Microscopy, Confocal; Mutation; Neoplasm Invasiveness; Polymerization; Receptors, LHRH; rhoA GTP-Binding Protein; Stress Fibers; Transfection	2012
Signaling and antiproliferative effects of type I and II gonadotropin-releasing hormone receptors in breast cancer cells. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:4 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Cell Division; Cell Line, Tumor; Chimera; Female; Gene Transfer Techniques; Humans; Molecular Conformation; Peptide Fragments; Receptors, LHRH; Sheep; Signal Transduction; Species Specificity; Xenopus laevis	2004
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer. Lancet (London, England), 1982, May-29, Volume: 1, Issue:8283 Topics: Adult; Anovulation; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis	1982
Analogues of gonadotrophin releasing hormone. British medical journal (Clinical research ed.), 1984, Feb-11, Volume: 288, Issue:6415 Topics: Animals; Breast Neoplasms; Buserelin; Child; Dogs; Female; Humans; Male; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Puberty, Precocious	1984
Long-term LHRH-agonist treatment in metastatic breast cancer as a single treatment and in combination with other additive endocrine treatments. Medical oncology and tumor pharmacotherapy, 1984, Volume: 1, Issue:2 Topics: Breast Neoplasms; Buserelin; Drug Therapy, Combination; Female; Humans; Megestrol; Megestrol Acetate; Tamoxifen	1984
Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer, 1993, Jul-15, Volume: 72, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyproterone; Drug Administration Schedule; Humans; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome	1993
Failure to detect gonadotrophin-releasing hormone receptors in human benign and malignant breast tissue and in MCF-7 and MDA-MB-231 cancer cells. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:2 Topics: Animals; Breast Neoplasms; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Pituitary Gland; Placenta; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Tumor Cells, Cultured	1993
Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters. Breast cancer research and treatment, 1993, Volume: 25, Issue:1 Topics: Amino Acid Sequence; Animals; Binding, Competitive; Biopsy; Breast Neoplasms; Buserelin; Female; Humans; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, LHRH; Receptors, Progesterone; S Phase	1993
Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors. The Journal of clinical endocrinology and metabolism, 1993, Volume: 77, Issue:4 Topics: Analysis of Variance; Breast Neoplasms; Buserelin; Cell Division; Dose-Response Relationship, Drug; Estradiol; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Neoplasms, Hormone-Dependent; Radioimmunoassay; Time Factors; Tumor Cells, Cultured	1993
Combined endocrine therapy for breast cancer--new life for an old idea? Journal of the National Cancer Institute, 2000, Jun-07, Volume: 92, Issue:11 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Buserelin; Confounding Factors, Epidemiologic; Disease-Free Survival; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Ovary; Premenopause; Randomized Controlled Trials as Topic; Research Design; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome	2000
Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. Journal of the National Cancer Institute, 2000, Dec-20, Volume: 92, Issue:24 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Premenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Research Design; Tamoxifen; Treatment Outcome	2000
Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 1992, Mar-15, Volume: 89, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Dose-Response Relationship, Drug; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Receptors, LHRH; Triptorelin Pamoate	1992
Differential effects of LHRH and somatostatin analogs on human breast cancer. The Journal of surgical research, 1992, Volume: 52, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma; Cell Division; Estrogens; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; In Vitro Techniques; Somatostatin; Triptorelin Pamoate; Tumor Cells, Cultured	1992
Novel antitumor peptide hormones and their effect on signal transduction. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3 Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Molecular Sequence Data; Peptides; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Signal Transduction; Somatostatin; Tumor Cells, Cultured	1992
Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 41, Issue:3-8 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cortisone; Female; Goserelin; Humans; Insulin-Like Growth Factor I; Menopause; Middle Aged; Tamoxifen	1992
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. British journal of cancer, 1992, Volume: 65, Issue:5 Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen	1992
Treatment of pre-menopausal advanced breast cancer with goserelin--a long-acting luteinizing hormone releasing hormone agonist. Anti-cancer drugs, 1992, Volume: 3, Issue:1 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Middle Aged; Progesterone	1992
[Buserelin therapy in postmenopausal patients with advanced breast carcinoma]. La Clinica terapeutica, 1991, Feb-15, Volume: 136, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone; Thyroid Hormones	1991
Medical castration with zoladex: a conservative approach to premenopausal breast cancer. Tumori, 1991, Apr-30, Volume: 77, Issue:2 Topics: Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Ovariectomy; Receptors, Estrogen	1991
[Report of the International Symposium on "Zoladex--the new therapy concept in breast cancer" Cambridge, 9-11 September 1990]. Zentralblatt fur Gynakologie, 1991, Volume: 113, Issue:6 Topics: Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent	1991
Combined goserelin and tamoxifen in premenopausal advanced breast cancer: duration of response and survival. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Middle Aged; Tamoxifen	1991
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7 Topics: Antibodies, Monoclonal; Breast Neoplasms; Buserelin; Cell Division; Female; Goserelin; Humans; Immunohistochemistry; Menopause; Predictive Value of Tests; Receptors, Estrogen; Tamoxifen	1991
Factors influencing the response of MCF-7 cells to an agonist of luteinising hormone-releasing hormone. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:11 Topics: Breast Neoplasms; Buserelin; Cell Line; Culture Media; Epidermal Growth Factor; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Insulin; Tumor Cells, Cultured	1991
Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1991, Volume: 12, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Buserelin; Cell Division; Gonadotropin-Releasing Hormone; Humans; Phospholipids; Protein Kinase C; Protein-Tyrosine Kinases; Signal Transduction; Thymidine; Tritium; Tumor Cells, Cultured	1991
Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle. British journal of cancer, 1991, Volume: 63, Issue:6 Topics: Breast Neoplasms; Buserelin; Cell Cycle; Cell Line; Clone Cells; Female; G1 Phase; Gonadotropin-Releasing Hormone; Humans; Kinetics; Resting Phase, Cell Cycle	1991
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. British journal of cancer, 1990, Volume: 61, Issue:1 Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen	1990
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1990, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen	1990
Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects. Annals of the New York Academy of Sciences, 1990, Volume: 595 Topics: Breast Neoplasms; Buserelin; Estradiol; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menopause; Polyunsaturated Alkamides; Tamoxifen	1990
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen	1990
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival. British journal of cancer, 1990, Volume: 62, Issue:5 Topics: Adult; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Receptors, Estrogen; Survival Rate; Time Factors	1990
CAF and nasal buserelin in the treatment of premenopausal women with metastatic breast cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:4 Topics: Administration, Intranasal; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged	1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Progesterone; Tamoxifen	1989
[Therapy with LHRH analogs in a 41-year-old patient with metastatic breast cancer]. Der Internist, 1989, Volume: 30, Issue:4 Topics: Adenocarcinoma; Adult; Breast Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Femoral Neoplasms; Gonadotropin-Releasing Hormone; Humans; Injections, Subcutaneous; Male; Tamoxifen; Triptorelin Pamoate	1989
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer. British journal of cancer, 1989, Volume: 59, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged; Tamoxifen	1989
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. British journal of cancer, 1989, Volume: 60, Issue:2 Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen	1989
[Zoladex as a depot GnRH agonist in premenopausal metastatic breast cancer]. Archives of gynecology and obstetrics, 1989, Volume: 245, Issue:1-4 Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Middle Aged	1989
Combined endocrine effects of LHRH agonist (Zoladex) and tamoxifen (Nolvadex) therapy in premenopausal women with breast cancer. The British journal of surgery, 1989, Volume: 76, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Middle Aged; Tamoxifen	1989
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Adult; Androstenedione; Breast Neoplasms; Buserelin; Estrone; Female; Goserelin; Humans; Middle Aged; Testosterone	1989
Zoladex in advanced breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Goserelin; Humans; Ovary; Tamoxifen	1989
Endocrinology of Zoladex in postmenopausal women. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Androgens; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause	1989
Zoladex: therapeutic effects in postmenopausal breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged	1989
Therapy in premenopausal women with advanced, oestrogen positive or/and progesterone positive breast cancer: surgical oophorectomy versus the LHRH analogue, Zoladex. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone	1989
LHRH analogues in early breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Cyclophosphamide; Female; Fluorouracil; Goserelin; Humans; Methotrexate; Middle Aged	1989
Clinical trials referral resource. Adjuvant therapy of breast cancer. Oncology (Williston Park, N.Y.), 1989, Volume: 3, Issue:6 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen	1989
A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist--Zoladex. Cancer letters, 1989, Nov-30, Volume: 48, Issue:2 Topics: Aged; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Female; Goserelin; Humans; Menopause	1989
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancer. Tumori, 1988, Jun-30, Volume: 74, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone	1988
[Gonadotropin-releasing hormone receptors in human breast cancer tissue]. Geburtshilfe und Frauenheilkunde, 1988, Volume: 48, Issue:6 Topics: Binding, Competitive; Breast; Breast Neoplasms; Buserelin; Female; Humans; Radioligand Assay; Receptors, Estrogen; Receptors, LHRH; Receptors, Progesterone	1988
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer. Journal of steroid biochemistry, 1985, Volume: 23, Issue:5B Topics: Adult; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Pituitary Gland; Progesterone; Receptors, Estrogen; Time Factors	1985
The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer. British journal of cancer, 1986, Volume: 53, Issue:5 Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Injections, Subcutaneous; Luteinizing Hormone; Middle Aged; Progesterone; Receptors, Estrogen	1986
Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer. The Journal of endocrinology, 1986, Volume: 111, Issue:2 Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged; Progesterone	1986
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630. British journal of cancer, 1986, Volume: 54, Issue:6 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lung Neoplasms; Luteinizing Hormone; Menopause; Middle Aged; Remission Induction	1986
Response in post-menopausal patients on ICI 118630. British journal of cancer, 1987, Volume: 55, Issue:4 Topics: Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Lung Neoplasms; Middle Aged	1987
Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin. The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:4 Topics: Aged; Aged, 80 and over; Androgens; Breast Neoplasms; Buserelin; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause; Middle Aged; Ovary	1988
Effect of LHRH agonist, Zoladex, on ovarian histology. The British journal of surgery, 1988, Volume: 75, Issue:6 Topics: Breast Neoplasms; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Menopause; Ovariectomy; Ovary	1988
[Therapy with gonadotropin releasing hormone agonists (zoladex) in premenopausal females with metastastic breast cancer]. Geburtshilfe und Frauenheilkunde, 1988, Volume: 48, Issue:7 Topics: Adult; Breast Neoplasms; Buserelin; Female; Follow-Up Studies; Gonadal Steroid Hormones; Goserelin; Humans; Injections, Subcutaneous; Middle Aged; Neoplasm Metastasis	1988
Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:3 Topics: Breast Neoplasms; Buserelin; Cell Line; DNA Replication; Gonadotropin-Releasing Hormone; Humans; Peptide Fragments; Receptors, LHRH; Thyrotropin-Releasing Hormone	1987
Treatment of breast cancer with gonadotropin-releasing hormone. Endocrine reviews, 1986, Volume: 7, Issue:1 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Tamoxifen	1986
Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro. Biochemical and biophysical research communications, 1986, Oct-30, Volume: 140, Issue:2 Topics: Breast Neoplasms; Buserelin; Cell Division; Cell Nucleus; Cytosol; Estradiol; Humans; In Vitro Techniques; Neoplasm Proteins; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Stem Cell Assay	1986
Nasally administered buserelin inducing complete remission of lung metastases in male breast cancer. Cancer, 1987, Feb-15, Volume: 59, Issue:4 Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Humans; Lung Neoplasms; Male; Middle Aged	1987
Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamide. Cancer, 1988, Aug-01, Volume: 62, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Flutamide; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Testosterone	1988
Complete estrogen blockade with buserelin and aminoglutethimide for advanced breast cancer: a phase I-II study with long-term hormonal correlations. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:6 Topics: Adult; Aminoglutethimide; Breast Neoplasms; Buserelin; Cortisone; Drug Evaluation; Drug Therapy, Combination; Estrogen Antagonists; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Receptors, Estrogen; Testosterone	1988
Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:3 Topics: Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone	1985
The treatment of postmenopausal women with advanced breast cancer with buserelin. Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2 Topics: Adenocarcinoma; Aged; Breast Neoplasms; Buserelin; Female; Gonadotropins, Pituitary; Humans; Hypophysectomy, Chemical; Lymphatic Metastasis; Menopause; Middle Aged; Time Factors	1985
Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:12 Topics: Breast Neoplasms; Buserelin; Cell Division; Cell Line; Culture Media; DNA, Neoplasm; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Neoplasm Proteins; Tamoxifen	1985